Syndax Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
33.14
|
|
Average Rating
|
4.56
|
|
# Strong Buys
|
5
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.63
|
-0.58
|
0.05
|
7.94%
|
|
2022-06-30
|
-0.64
|
-0.62
|
0.02
|
3.13%
|
|
2022-03-31
|
-0.63
|
-0.63
|
0.00
|
0.00%
|
|
2021-12-31
|
0.28
|
1.81
|
1.53
|
546.43%
|
|
2021-09-30
|
-0.23
|
-0.40
|
-0.17
|
-73.91%
|
|
2021-06-30
|
-0.71
|
-0.44
|
0.27
|
38.03%
|
|
2021-03-31
|
-0.65
|
-0.54
|
0.11
|
16.92%
|
|
2020-12-31
|
-0.49
|
-0.44
|
0.05
|
10.20%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.83
|
|
2021-12-31
|
0.43
|
|
2020-12-31
|
-1.88
|
|
2019-12-31
|
-1.85
|
|
2018-12-31
|
-2.91
|
|
2017-12-31
|
-2.89
|
|
2016-12-31
|
-4.75
|